Compare $HCWB vs $ONCO | Chartloom

Compare

$HCWB vs $ONCO

HCW Biologics Inc · Onconetix Inc

HCWB

HCW Biologics Inc

ONCO

Onconetix Inc

Compare $HCWB vs $ONCO

Comparing HCW Biologics Inc and Onconetix Inc

HCWBHCW Biologics Inc

ONCOOnconetix Inc

HCWBHCW Biologics Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

707.0%

YTD performance

-76.2%

52W performance

-94.5%

FCF yield

-474.1%

ONCOOnconetix Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-51.3%

YTD performance

-99.2%

52W performance

-99.7%

FCF yield

-420.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

HCWB

ONCO

Detailed metrics comparison

HCWB

HCW Biologics Inc

ONCO

Onconetix Inc

Market Cap

HCWB$3M

ONCO$2M

Enterprise Value

HCWB$8M

ONCO$-3M

Price

HCWB$1.60

ONCO$0.62

P/E Ratio

HCWBN/A

ONCON/A

P/S Ratio

HCWB0.38x

ONCO3.79x

EV/Sales

HCWB1.25x

ONCO-5.18x

EV/EBITDA

HCWB0.00x

ONCO0.00x

P/B Ratio

HCWB0.51x

ONCO0.24x

P/FCF Ratio

HCWBN/A

ONCON/A

EV/FCF

HCWB-0.69x

ONCO0.32x

PEG Ratio

HCWBN/A

ONCON/A

Forward P/E (NTM)

HCWBN/A

ONCON/A

Forward P/S (NTM)

HCWBN/A

ONCON/A

Revenue (TTM)

HCWB$7M

ONCO$646K

Revenue Growth (YoY)

HCWB707.0%

ONCO-51.3%

Forward Rev Growth

HCWB5564.5%

ONCO0.0%

Gross Margin (TTM)

HCWB95.9%

ONCO80.4%

Operating Margin (TTM)

HCWB23.1%

ONCO0.0%

EBITDA Margin (TTM)

HCWB-82.2%

ONCO-1188.1%

Net Margin (TTM)

HCWB-318.5%

ONCO-1578.8%

FCF Margin (TTM)

HCWB-180.6%

ONCO-1596.2%

Net Income (TTM)

HCWB$-21M

ONCO$-10M

FCF (TTM)

HCWB$-12M

ONCO$-10M

EPS (TTM)

HCWB-$16.12

ONCO-$4.55

ROE (TTM)

HCWB-1932.0%

ONCO-9194.0%

ROA (TTM)

HCWB-2145.0%

ONCO-5376.0%

ROIC (TTM)

HCWB-859.0%

ONCO-9080.0%

Cash

HCWB$741K

ONCO$6M

Debt

HCWB$7M

ONCO$150K

Net Cash/Debt

HCWB$-6M

ONCO$6M

Current Ratio (TTM)

HCWB0.06x

ONCO2.21x

Quick Ratio (TTM)

HCWB0.05x

ONCO2.04x

Debt/Equity (TTM)

HCWB0.88x

ONCO0.01x

Debt/Assets (TTM)

HCWB0.0%

ONCO0.0%

Interest Coverage (TTM)

HCWBN/A

ONCON/A

Net Debt/EBITDA (TTM)

HCWB0.00x

ONCO0.00x

Beta

HCWB2.28

ONCO2.60

52W Performance

HCWB-94.5%

ONCO-99.7%

YTD Performance

HCWB-76.2%

ONCO-99.2%

% from 52W High

HCWB-94.3%

ONCO-99.7%

% from 52W Low

HCWB6.7%

ONCO6.9%

Asset Turnover (TTM)

HCWB0.26x

ONCO0.03x

FCF Yield (TTM)

HCWB-474.1%

ONCO-420.9%

Earnings Yield (TTM)

HCWB-836.3%

ONCO-416.3%

Dividend Yield (TTM)

HCWBN/A

ONCON/A

Rule of 40

HCWB526.4

ONCO-1,647.5

EV/GP/RG

HCWB0.00

ONCON/A

Ticker research

View HCWB research View ONCO research

Metric	HCWB HCW Biologics Inc	ONCO Onconetix Inc
Market & Valuation
Market Cap	$3M	$2M
Enterprise Value	$8M	$-3M
Price	$1.60	$0.62
P/E Ratio	N/A	N/A
P/S Ratio	0.38x	3.79x
EV/Sales	1.25x	-5.18x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.51x	0.24x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.69x	0.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$7M	$646K
Revenue Growth (YoY)	707.0%	-51.3%
Forward Rev Growth	5564.5%	0.0%
Profitability
Gross Margin (TTM)	95.9%	80.4%
Operating Margin (TTM)	23.1%	0.0%
EBITDA Margin (TTM)	-82.2%	-1188.1%
Net Margin (TTM)	-318.5%	-1578.8%
FCF Margin (TTM)	-180.6%	-1596.2%
Net Income (TTM)	$-21M	$-10M
FCF (TTM)	$-12M	$-10M
EPS (TTM)	-$16.12	-$4.55
ROE (TTM)	-1932.0%	-9194.0%
ROA (TTM)	-2145.0%	-5376.0%
ROIC (TTM)	-859.0%	-9080.0%
Financial Health
Cash	$741K	$6M
Debt	$7M	$150K
Net Cash/Debt	$-6M	$6M
Current Ratio (TTM)	0.06x	2.21x
Quick Ratio (TTM)	0.05x	2.04x
Debt/Equity (TTM)	0.88x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.28	2.60
52W Performance	-94.5%	-99.7%
YTD Performance	-76.2%	-99.2%
% from 52W High	-94.3%	-99.7%
% from 52W Low	6.7%	6.9%
Efficiency & Yields
Asset Turnover (TTM)	0.26x	0.03x
FCF Yield (TTM)	-474.1%	-420.9%
Earnings Yield (TTM)	-836.3%	-416.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	526.4	-1,647.5
EV/GP/RG	0.00	N/A
Ticker research	View HCWB research	View ONCO research

Valuation

P/S Ratio

HCWB

0.38x

ONCO

3.79x

EV/FCF

HCWB

-0.69x

ONCO

0.32x

Growth & revenue

Revenue Growth TTM

HCWB

707.0%

ONCO

-51.3%

Forward Revenue Growth

HCWB

5564.5%

ONCO

0.0%

Profitability & performance

Gross Margin

HCWB

95.9%

ONCO

80.4%

ROE

HCWB

-1932.0%

ONCO

-9194.0%

FCF Yield %

ONCO

-420.9%

HCWB

-474.1%

52-Week Performance

HCWB

-94.5%

ONCO

-99.7%

Detailed metrics comparison

HCWB

HCW Biologics Inc

ONCO

Onconetix Inc

Market Cap

HCWB$3M

ONCO$2M

Enterprise Value

HCWB$8M

ONCO$-3M

Price

HCWB$1.60

ONCO$0.62

P/E Ratio

HCWBN/A

ONCON/A

P/S Ratio

HCWB0.38x

ONCO3.79x

EV/Sales

HCWB1.25x

ONCO-5.18x

EV/EBITDA

HCWB0.00x

ONCO0.00x

P/B Ratio

HCWB0.51x

ONCO0.24x

P/FCF Ratio

HCWBN/A

ONCON/A

EV/FCF

HCWB-0.69x

ONCO0.32x

PEG Ratio

HCWBN/A

ONCON/A

Forward P/E (NTM)

HCWBN/A

ONCON/A

Forward P/S (NTM)

HCWBN/A

ONCON/A

Revenue (TTM)

HCWB$7M

ONCO$646K

Revenue Growth (YoY)

HCWB707.0%

ONCO-51.3%

Forward Rev Growth

HCWB5564.5%

ONCO0.0%

Gross Margin (TTM)

HCWB95.9%

ONCO80.4%

Operating Margin (TTM)

HCWB23.1%

ONCO0.0%

EBITDA Margin (TTM)

HCWB-82.2%

ONCO-1188.1%

Net Margin (TTM)

HCWB-318.5%

ONCO-1578.8%

FCF Margin (TTM)

HCWB-180.6%

ONCO-1596.2%

Net Income (TTM)

HCWB$-21M

ONCO$-10M

FCF (TTM)

HCWB$-12M

ONCO$-10M

EPS (TTM)

HCWB-$16.12

ONCO-$4.55

ROE (TTM)

HCWB-1932.0%

ONCO-9194.0%

ROA (TTM)

HCWB-2145.0%

ONCO-5376.0%

ROIC (TTM)

HCWB-859.0%

ONCO-9080.0%

Cash

HCWB$741K

ONCO$6M

Debt

HCWB$7M

ONCO$150K

Net Cash/Debt

HCWB$-6M

ONCO$6M

Current Ratio (TTM)

HCWB0.06x

ONCO2.21x

Quick Ratio (TTM)

HCWB0.05x

ONCO2.04x

Debt/Equity (TTM)

HCWB0.88x

ONCO0.01x

Debt/Assets (TTM)

HCWB0.0%

ONCO0.0%

Interest Coverage (TTM)

HCWBN/A

ONCON/A

Net Debt/EBITDA (TTM)

HCWB0.00x

ONCO0.00x

Beta

HCWB2.28

ONCO2.60

52W Performance

HCWB-94.5%

ONCO-99.7%

YTD Performance

HCWB-76.2%

ONCO-99.2%

% from 52W High

HCWB-94.3%

ONCO-99.7%

% from 52W Low

HCWB6.7%

ONCO6.9%

Asset Turnover (TTM)

HCWB0.26x

ONCO0.03x

FCF Yield (TTM)

HCWB-474.1%

ONCO-420.9%

Earnings Yield (TTM)

HCWB-836.3%

ONCO-416.3%

Dividend Yield (TTM)

HCWBN/A

ONCON/A

Rule of 40

HCWB526.4

ONCO-1,647.5

EV/GP/RG

HCWB0.00

ONCON/A

Ticker research

View HCWB research View ONCO research

Metric	HCWB HCW Biologics Inc	ONCO Onconetix Inc
Market & Valuation
Market Cap	$3M	$2M
Enterprise Value	$8M	$-3M
Price	$1.60	$0.62
P/E Ratio	N/A	N/A
P/S Ratio	0.38x	3.79x
EV/Sales	1.25x	-5.18x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.51x	0.24x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.69x	0.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$7M	$646K
Revenue Growth (YoY)	707.0%	-51.3%
Forward Rev Growth	5564.5%	0.0%
Profitability
Gross Margin (TTM)	95.9%	80.4%
Operating Margin (TTM)	23.1%	0.0%
EBITDA Margin (TTM)	-82.2%	-1188.1%
Net Margin (TTM)	-318.5%	-1578.8%
FCF Margin (TTM)	-180.6%	-1596.2%
Net Income (TTM)	$-21M	$-10M
FCF (TTM)	$-12M	$-10M
EPS (TTM)	-$16.12	-$4.55
ROE (TTM)	-1932.0%	-9194.0%
ROA (TTM)	-2145.0%	-5376.0%
ROIC (TTM)	-859.0%	-9080.0%
Financial Health
Cash	$741K	$6M
Debt	$7M	$150K
Net Cash/Debt	$-6M	$6M
Current Ratio (TTM)	0.06x	2.21x
Quick Ratio (TTM)	0.05x	2.04x
Debt/Equity (TTM)	0.88x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.28	2.60
52W Performance	-94.5%	-99.7%
YTD Performance	-76.2%	-99.2%
% from 52W High	-94.3%	-99.7%
% from 52W Low	6.7%	6.9%
Efficiency & Yields
Asset Turnover (TTM)	0.26x	0.03x
FCF Yield (TTM)	-474.1%	-420.9%
Earnings Yield (TTM)	-836.3%	-416.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	526.4	-1,647.5
EV/GP/RG	0.00	N/A
Ticker research	View HCWB research	View ONCO research